HomeTopotecanTopotecan + Sofosbuvir Velpatasvir And Voxilaprevir

Does Topotecan Interact with Sofosbuvir Velpatasvir And Voxilaprevir?

Topotecan and Sofosbuvir Velpatasvir And Voxilaprevir have a major drug interaction according to U.S. FDA drug labeling data. BCRP substrate whose exposure may be altered by velpatasvir and voxilaprevir inhibition. Coadministration is not recommended. The mechanism involves bcrp inhibition by velpatasvir and voxilaprevir. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Topotecan Class
Topoisomerase Inhibitor
Sofosbuvir Velpatasvir And Voxilaprevir Class
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Topotecan and Sofosbuvir Velpatasvir And Voxilaprevir occurs because bcrp inhibition by velpatasvir and voxilaprevir. Clinically, this means bcrp substrate whose exposure may be altered by velpatasvir and voxilaprevir inhibition. coadministration is not recommended. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Topotecan and your doctor is considering prescribing Sofosbuvir Velpatasvir And Voxilaprevir (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Topotecan(Topotecan)+💊 Sofosbuvir Velpatasvir And Voxilaprevir(Vosevi)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Topoisomerase Inhibitor
Drug B class
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
Source
NLP:sofosbuvir, velpatasvir, and voxilaprevir

What this means in plain English

BCRP substrate whose exposure may be altered by velpatasvir and voxilaprevir inhibition. Coadministration is not recommended.

What the FDA label says

"BCRP inhibition by velpatasvir and voxilaprevir"

📖 Source: NLP:sofosbuvir, velpatasvir, and voxilaprevir

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Topotecan and Sofosbuvir Velpatasvir And Voxilaprevir against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.